PULMONARY FIBROSIS FOUNDATION (EIN 841558631) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

SCOTT STASZAK

Phone

3122652182

Tax Period

2024-07-01 to 2025-06-30

PULMONARY FIBROSIS FOUNDATION, founded in 2000, is a community nonprofit in the Diseases & Disorders sector that reported $9.3M in total revenue in fiscal year 2024. Revenue grew 12% year-over-year, indicating healthy expansion. The organization ran a surplus of $1.9M, a strong 20% operating margin.

Mission

TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS AND ULTIMATELY A CURE FOR PULMONARY FIBROSIS. UNTIL THIS GOAL IS ACHIEVED, THE PFF IS COMMITTED TO ADVANCING IMPROVED CARE OF PATIENTS WITH PF AND PROVIDING UNEQUALED SUPPORT AND EDUCATION RESOURCES FOR PATIENTS, CAREGIVERS, FAMILY MEMBERS, AND HEALTH CARE PROVIDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $7,996,521

Program Service Revenue $1,581,702

Investment Income $632,494

Other Revenue $-959,518

TOTAL REVENUE $9,251,199

Expense Breakdown

Grants Paid $620,294

Salaries & Benefits $4,134,984

Fundraising Expenses $1,146,352

Program Expenses $4,950,416

Other Expenses $2,618,060

TOTAL EXPENSES $7,373,338

Year-over-Year Comparison

	2024	2023	Change
Revenue	$9,251,199	$8,276,217	+0.1%
Expenses	$7,373,338	$9,009,001	-0.2%
Net Income	$1,877,861	$-732,784	-3.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

4833

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$639,741

Total Directors

Key Employees

$216,084

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SCOTT STASZAK	PRESIDENT & CEO	40.00	Officer	$421,578	$11,090	$432,668
FRANCK RAHAGHI	FORMER PRESIDENT & CEO	40.00		$284,230	$5,808	$290,038
SETH KLEIN	CHIEF DEVELOPMENT OFFICER	40.00	Key Emp	$209,028	$7,056	$216,084
JESSICA SHORE	SR. VP, CLINICAL AFFAIRS AND QUALITY	40.00	Highest	$202,398	$7,013	$209,411
JANET BIANCHETTA	CHIEF FINANCIAL OFFICER	40.00	Officer	$184,343	$22,730	$207,073
KATHERINE BEIN	VP, ADVOCACY AND PROGRAMS	40.00	Highest	$158,916	$31,572	$190,488
JENNIFER MEFFORD	VP, CORPORATE PARTNERSHIPS	40.00	Highest	$172,561	$6,088	$178,649
ZOE BUBANY	VP, BOARD AND EXTERNAL RELATIONS	40.00	Highest	$141,984	$21,979	$163,963
AMY WARDZALA	VP, DEVELOPMENT	40.00	Highest	$132,201	$27,443	$159,644
WAYNE PAN MD PHD MBA	CHAIR	1.00	Officer Director	$0	$0	$0
PATRICIA ROSA	VICE CHAIR	1.00	Officer Director	$0	$0	$0
MARTIN ATTWELL	SECRETARY	1.00	Officer Director	$0	$0	$0
LAURIE CHANDLER CFP	TREASURER	1.00	Officer Director	$0	$0	$0
GRANT BALLANTYNE	DIRECTOR	1.00	Director	$0	$0	$0
HAROLD R COLLARD MD	DIRECTOR	1.00	Director	$0	$0	$0
TERENCE HALES	DIRECTOR	1.00	Director	$0	$0	$0
JULIE HALSTON	DIRECTOR	1.00	Director	$0	$0	$0
JEFF HARRIS	DIRECTOR	1.00	Director	$0	$0	$0
SUSAN JACOBS RN MS	DIRECTOR	1.00	Director	$0	$0	$0
HEATHER KAGEL	DIRECTOR	1.00	Director	$0	$0	$0
PJ KAMANI	DIRECTOR	1.00	Director	$0	$0	$0
DEVI KUMAR-NAMBIAR JD MBA	DIRECTOR	1.00	Director	$0	$0	$0
DAVID MCNINCH	DIRECTOR	1.00	Director	$0	$0	$0
WILLIAM SCHMIDT	DIRECTOR	1.00	Director	$0	$0	$0
KENNETH FANG MD	DIRECTOR - TERM	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$9,251,199	$7,373,338	$17,464,989	$1,877,861
2024	$8,276,217	$9,009,001	$15,320,155	$-732,784
2023	$11,816,537	$10,341,815	$16,794,445	$1,474,722
2022	$11,007,903	$9,685,619	$17,064,469	$1,322,284
2021	$8,965,595	$8,341,845	$14,745,592	$623,750
2020	$10,702,044	$11,291,623	$10,892,804	$-589,579
2019	$10,448,685	$8,488,184	$10,914,467	$1,960,501
2018	$8,743,466	$8,344,215	$8,884,514	$399,251

PULMONARY FIBROSIS FOUNDATION